Correlation Between Apellis Pharmaceuticals and Prometheus Biosciences

Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Prometheus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Prometheus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apellis Pharmaceuticals and Prometheus Biosciences, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Prometheus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Prometheus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Prometheus Biosciences.

Diversification Opportunities for Apellis Pharmaceuticals and Prometheus Biosciences

0.0

Correlation Coefficient

Apellis Pharmaceuticals  Prometheus Biosciences

Pay attention - limited upside

The 3 months correlation between Apellis and Prometheus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Prometheus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prometheus Biosciences and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Prometheus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prometheus Biosciences has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Prometheus Biosciences go up and down completely randomly.

Pair Corralation between Apellis Pharmaceuticals and Prometheus Biosciences

If you would invest (100.00) in Prometheus Biosciences on December 30, 2024 and sell it today you would earn a total of  100.00  from holding Prometheus Biosciences or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Apellis Pharmaceuticals  vs.  Prometheus Biosciences

Apellis Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Apellis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Prometheus Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Prometheus Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Prometheus Biosciences is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Apellis Pharmaceuticals and Prometheus Biosciences

The main advantage of trading using opposite Apellis Pharmaceuticals and Prometheus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Prometheus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prometheus Biosciences will offset losses from the drop in Prometheus Biosciences' long position.

The idea behind Apellis Pharmaceuticals and Prometheus Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.